Evidence map›Paper›PMID 40827719›Full record

ArticlePediatric pulmonology2025

Long-Term Outcomes of Necrotizing Pneumonia and Parapneumonic Effusion in Children.

Sinem Can Oksay, Begüm Yörük, Şeyda Karabulut, Hüseyin Arslan, Gülay Bilgin, Füsun Ünal, Deniz Mavi Tortop, Ebru Köstereli, Zeynep Reyhan Onay, Yasemin Gokdemir and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Pediatric pulmonology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Analysis of the pathogens and clinical characteristics of pediatric necrotizing pneumonia patients in a tertiary grade a hospital from 2019 to 2025: a retrospective study design.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sinem Can OksayDivision of Pediatric Pulmonology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.ORCID 0000-0001-9801-3181
Begüm YörükDivision of Pediatric Pulmonology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.ORCID 0000-0001-6599-9802
Şeyda KarabulutDivision of Pediatric Pulmonology, Faculty of Medicine, Marmara University, Istanbul, Turkiye.ORCID 0000-0002-4606-8946
Hüseyin ArslanDivision of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkiye.ORCID 0000-0002-2655-5894
Gülay BilginDivision of Pediatric Pulmonology, Eskişehir City Hospital, Eskişehir, Turkiye.ORCID 0000-0001-6207-3748
Füsun ÜnalDivision of Pediatric Pulmonology, Faculty of Medicine, Medipol University, Istanbul, Turkiye.ORCID 0000-0002-2796-2694
Deniz Mavi TortopDivision of Pediatric Pulmonology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.ORCID 0000-0002-9134-5658
Ebru KöstereliDivision of Pediatric Pulmonology, Faculty of Medicine, Koc University, Istanbul, Turkiye.ORCID 0000-0003-3800-5352
Zeynep Reyhan OnayDivision of Pediatric Pulmonology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.ORCID 0000-0002-1251-6720
Yasemin GokdemirDivision of Pediatric Pulmonology, Faculty of Medicine, Marmara University, Istanbul, Turkiye.ORCID 0000-0002-0853-7932
Zeynep Seda UyanDivision of Pediatric Pulmonology, Faculty of Medicine, Koc University, Istanbul, Turkiye.ORCID 0000-0002-7540-3467
Ela Erdem EralpDivision of Pediatric Pulmonology, Faculty of Medicine, Marmara University, Istanbul, Turkiye.ORCID 0000-0001-8829-3431
Ayse Ayzıt KilincDivision of Pediatric Pulmonology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkiye.ORCID 0000-0002-2879-8910
Ali ÖzdemirDivision of Pediatric Pulmonology, Mersin City Education and Training Hospital, Mersin, Turkiye.ORCID 0000-0001-7340-0409
Velat ŞenDivision of Pediatric Pulmonology, Faculty of Medicine, Dicle University, Diyarbakır, Turkiye.ORCID 0000-0002-9232-5982
Erkan CakirDivision of Pediatric Pulmonology, Faculty of Medicine, Istinye University, Istanbul, Turkiye.ORCID 0000-0002-1438-7854
Saniye GiritDivision of Pediatric Pulmonology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.ORCID 0000-0001-7556-6568

Funding

The authors received no specific funding for this study.
6 · The paper itself

Abstract

backgroundComplications such as parapneumonic effusion (PPE) and necrotizing pneumonia (NP) can be noted in 3% of patients with community-acquired pneumonia and may cause functional lung damage.

objectiveWe aimed to investigate the short- and long-term effects of PPE and NP on lung function and the impact of treatment modalities and radiological sequelae on results. MATERIAL AND

methodsThis multicenter retrospective study includes children aged 0-18 years hospitalized for PPE and NP after community-acquired pneumonia. Demographic, clinical, radiological, and spirometry findings were collected during diagnosis and follow-up.

resultsOf 123 children (62 female, median age 57 [interquartile range 71.5] months), 78 were diagnosed with NP and 45 with PPE. According to the defined periods, spirometric evaluation was performed in the first 3 months in 23 patients, between the 3rd and 6th months in 27 patients, and between the 6th and 9th months in 37 patients. At 3 months post-discharge, abnormal spirometry (18.18% restrictive, 36.36% combined spirometry) was observed with a rate of 54.54% in NP, and with a rate of 25.0% (8.33% restrictive, 16.66% combined spirometry) in PPE. At 6-9 months, normal spirometry was observed with a rate of 87% in both groups. FVC% values increased over time in both the NP and PPE groups; however, statistically significant improvement was observed only in the PPE group. In this group, FVC% was significantly higher in the patients who received antibiotics with chest tube and/or fibrinolytic therapy (p = 0.022). Furthermore, those without radiological sequelae had significantly higher FVC% values compared to those with sequelae (p = 0.023) in the PPE group.

conclusionRadiological sequelae and restrictive spirometric patterns were initially more common in NP compared to PPE. However, spirometry indicated significant improvement in both groups by the end of the 9-month follow-up period.

Indexed as

Community-Acquired InfectionsPleural EffusionPneumonia, NecrotizingAdolescentAnti-Bacterial AgentsChildChild, PreschoolFemaleHumansInfantInfant, NewbornLungMaleRetrospective StudiesSpirometryTreatment OutcomeAnti-Bacterial Agentslong‐term outcomesnecrotizing pneumoniaparapneumonic effusionradiologic sequelaespirometry

Identifiers

PMID40827719
PMCPMC12363156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.